Andrei Purysko, MD presented “Quality Improvement American College of Radiology Program in Prostate MRI” during the 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 21, 2023.
How to cite: Purysko, Andrei. “Quality Improvement American College of Radiology Program in Prostate MRI.” September 21, 2023. Accessed Nov 2024. https://grandroundsinurology.com/quality-improvement-american-college-of-radiology-program-in-prostate-mri/
Quality Improvement American College of Radiology Program in Prostate MRI – Summary
Dr. Andrei Purysko, MD, presents an overview of the Quality Improvement American College of Radiology (ACR) Program in Prostate MRI. He underscores the critical role that prostate MRI plays in the diagnosis and management of prostate cancer.
Purysko elaborates on the methodology of the ACR program, which encompasses standardized protocols, rigorous training, and certification processes for radiologists. He details the program’s key components, such as the development of evidence-based guidelines and the implementation of performance metrics to continually assess and enhance radiologist proficiency, and the impact of these measures on patient outcomes.
Purysko presents data illustrating that adherence to standardized MRI protocols can significantly improve the detection rates of clinically significant prostate cancers. This improvement facilitates timely and appropriate treatment, ultimately benefiting patient care.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
